Tissue factor gene promoter haplotype associates with carotid intima-media thickness in subjects in cardiovascular risk prevention

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 168-173

  Gertow, Karl ^a   Amato, Mauro ^a   Werba, José Pablo ^a   Bianchi, Elena ^a   Parolari, Alessandro ^a   Colnago, Deborah ^a   Brambilla, Marta ^a   Ravani, Alessio ^a   Veglia, Fabrizio ^a   Baldassarre, Damiano ^a,b   Camera, Marina ^a,b   Tremoli, Elena ^a,b  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Atherosclerosis; Carotid intima media thickness; Genetic polymorphism; Tissue factor

Indexed keywords

ADENINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GUANINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THROMBOPLASTIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROMOTER REGION; SECONDARY PREVENTION;

CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; THROMBOPLASTIN; TUNICA INTIMA; TUNICA MEDIA;

EID: 70350513741     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.040     Document Type: Article

References (31)

1. Wilcox J.N., Smith K.M., Schwartz S.M., and Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 86 (1989) 2839-2843
2. Steffel J., Luscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113 (2006) 722-731
3. Tremoli E., Camera M., Toschi V., and Colli S. Tissue factor in atherosclerosis. Atherosclerosis 144 (1999) 273-283
4. Marmur J.D., Thiruvikraman S.V., Fyfe B.S., et al. Identification of active tissue factor in human coronary atheroma. Circulation 94 (1996) 1226-1232
5. Thiruvikraman S.V., Guha A., Roboz J., et al. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 75 (1996) 451-461
6. Mallat Z., Hugel B., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99 (1999) 348-353
7. Toschi V., Gallo R., Lettino M., et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95 (1997) 594-599
8. Badimon J.J., Lettino M., Toschi V., et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 99 (1999) 1780-1787
9. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24 (2004) 1015-1022
10. Versteeg H.H., and Ruf W. Emerging insights in tissue factor-dependent signaling events. Semin Thromb Hemost 32 (2006) 24-32
11. Arnaud E., Barbalat V., Nicaud V., et al. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Temoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol 20 (2000) 892-898
12. Campo G., Valgimigli M., Ferraresi P., et al. Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol 26 (2006) 2800-2806
13. Malarstig A., Tenno T., Johnston N., et al. Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 25 (2005) 2667-2672
14. Marsik C., Endler G., Halama T., et al. Polymorphism in the tissue factor region is associated with basal but not endotoxin-induced tissue factor-mRNA levels in leukocytes. J Thromb Haemost 4 (2006) 745-749
15. Ott I., Koch W., von Beckerath N., et al. Tissue factor promotor polymorphism-603 A/G is associated with myocardial infarction. Atherosclerosis 177 (2004) 189-191
16. Reny J.L., Laurendeau I., Fontana P., et al. The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers. Thromb Haemost 91 (2004) 248-254
17. Terry C.M., Kling S.J., Cheang K.I., Hoidal J.R., and Rodgers G.M. Polymorphisms in the 5′-UTR of the tissue factor gene are associated with altered expression in human endothelial cells. J Thromb Haemost 2 (2004) 1351-1358
18. Baldassarre D., Amato M., Bondioli A., Sirtori C.R., and Tremoli E. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 31 (2000) 2426-2430
19. Stephens M., and Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 76 (2005) 449-462
20. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
21. Ilveskoski E., Loimaala A., Mercuri M.F., et al. Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men. Atherosclerosis 153 (2000) 147-153
22. Temelkova-Kurktschiev T.S., Koehler C., Leonhardt W., et al. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care 22 (1999) 333-338
23. Alagona C., Soro A., Westerbacka J., et al. Low HDL cholesterol concentration is associated with increased intima-media thickness independent of arterial stiffness in healthy subjects from families with low HDL cholesterol. Eur J Clin Invest 33 (2003) 457-463
24. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
25. Carmeliet P., Mackman N., Moons L., et al. Role of tissue factor in embryonic blood vessel development. Nature 383 (1996) 73-75
26. Cirillo P., Cali G., Golino P., et al. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation 109 (2004) 2911-2916
27. Ott I., Michaelis C., Schuermann M., et al. Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor. Circ Res 97 (2005) 293-298
28. Ott I., Weigand B., Michl R., et al. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. Circulation 111 (2005) 349-355
29. Pyo R.T., Sato Y., Mackman N., and Taubman M.B. Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration. Thromb Haemost 92 (2004) 451-458
30. Sharma L., Melis E., Hickey M.J., et al. The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia. Am J Pathol 165 (2004) 331-340
31. Pawlak K., Pawlak D., and Mysliwiec M. Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients. Thromb Haemost 92 (2004) 646-653